Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 26 | 2024 | 5145 | 2.070 |
Why?
|
Paraproteinemias | 7 | 2022 | 250 | 1.570 |
Why?
|
Necrobiotic Xanthogranuloma | 3 | 2017 | 10 | 0.740 |
Why?
|
Melphalan | 3 | 2023 | 420 | 0.720 |
Why?
|
Neoplasm, Residual | 1 | 2024 | 1008 | 0.640 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 617 | 0.540 |
Why?
|
Hemolysis | 1 | 2017 | 415 | 0.500 |
Why?
|
Immunoglobulin Isotypes | 1 | 2015 | 158 | 0.490 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2024 | 8531 | 0.460 |
Why?
|
Hematologic Diseases | 1 | 2017 | 496 | 0.440 |
Why?
|
Immunoglobulin A | 1 | 2015 | 979 | 0.390 |
Why?
|
Xanthomatosis | 1 | 2011 | 32 | 0.380 |
Why?
|
DNA Repair | 2 | 2019 | 2041 | 0.380 |
Why?
|
Amyloidosis | 3 | 2023 | 865 | 0.370 |
Why?
|
Emergencies | 1 | 2017 | 1217 | 0.360 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2010 | 38 | 0.350 |
Why?
|
Cryoglobulinemia | 3 | 2016 | 84 | 0.340 |
Why?
|
Waldenstrom Macroglobulinemia | 4 | 2023 | 1074 | 0.340 |
Why?
|
Antigens, Nuclear | 1 | 2010 | 184 | 0.330 |
Why?
|
Antibodies, Antinuclear | 1 | 2010 | 342 | 0.310 |
Why?
|
Sjogren's Syndrome | 1 | 2010 | 238 | 0.300 |
Why?
|
Heart | 2 | 2022 | 4431 | 0.300 |
Why?
|
Skin Diseases | 2 | 2015 | 1095 | 0.290 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5666 | 0.280 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3634 | 0.280 |
Why?
|
Kidney | 4 | 2024 | 7033 | 0.280 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9187 | 0.280 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5842 | 0.250 |
Why?
|
Liver | 1 | 2020 | 7512 | 0.240 |
Why?
|
Prognosis | 10 | 2024 | 29688 | 0.230 |
Why?
|
Mesenchymal Stem Cells | 2 | 2024 | 1645 | 0.170 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 179 | 0.170 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2024 | 634 | 0.170 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2019 | 199 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9278 | 0.160 |
Why?
|
Genomic Instability | 2 | 2020 | 709 | 0.160 |
Why?
|
Humans | 48 | 2024 | 761222 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 11733 | 0.150 |
Why?
|
Plasmapheresis | 2 | 2016 | 207 | 0.150 |
Why?
|
Xeroderma Pigmentosum | 1 | 2017 | 31 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 2157 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1527 | 0.140 |
Why?
|
Plasma Exchange | 1 | 2017 | 159 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 106 | 0.130 |
Why?
|
p21-Activated Kinases | 1 | 2017 | 127 | 0.130 |
Why?
|
Disease Management | 2 | 2024 | 2507 | 0.130 |
Why?
|
Leukemia, Lymphoid | 1 | 2016 | 311 | 0.130 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3875 | 0.130 |
Why?
|
Genome, Human | 2 | 2019 | 4423 | 0.130 |
Why?
|
Combined Modality Therapy | 4 | 2021 | 8519 | 0.130 |
Why?
|
Cyclophosphamide | 3 | 2016 | 2219 | 0.130 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1600 | 0.120 |
Why?
|
Ubiquitin | 1 | 2019 | 839 | 0.120 |
Why?
|
Autoimmunity | 2 | 2015 | 1356 | 0.120 |
Why?
|
Hypertension, Portal | 1 | 2017 | 227 | 0.120 |
Why?
|
Survival Rate | 5 | 2020 | 12728 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1226 | 0.110 |
Why?
|
Aged | 17 | 2024 | 169292 | 0.110 |
Why?
|
Dexamethasone | 5 | 2023 | 1945 | 0.110 |
Why?
|
Oncogenes | 1 | 2018 | 1220 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2014 | 4537 | 0.100 |
Why?
|
Kidney Diseases | 3 | 2024 | 2092 | 0.100 |
Why?
|
Opportunistic Infections | 1 | 2015 | 376 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1360 | 0.100 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 16954 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9417 | 0.100 |
Why?
|
Prevalence | 3 | 2024 | 15721 | 0.100 |
Why?
|
DNA Helicases | 1 | 2017 | 850 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1767 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 734 | 0.100 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.090 |
Why?
|
Chemokines | 1 | 2015 | 956 | 0.090 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 548 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13511 | 0.090 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58952 | 0.090 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2112 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2017 | 1838 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 5773 | 0.090 |
Why?
|
Genomics | 4 | 2019 | 5829 | 0.090 |
Why?
|
Female | 20 | 2024 | 392552 | 0.090 |
Why?
|
Middle Aged | 12 | 2024 | 220858 | 0.080 |
Why?
|
Cytokines | 2 | 2015 | 7386 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2016 | 1264 | 0.080 |
Why?
|
Meningitis, Aseptic | 1 | 2009 | 59 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1182 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3430 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1603 | 0.080 |
Why?
|
Translocation, Genetic | 3 | 2021 | 1391 | 0.080 |
Why?
|
Fabry Disease | 1 | 2009 | 87 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10088 | 0.080 |
Why?
|
Immunoglobulin Light Chains | 2 | 2023 | 286 | 0.080 |
Why?
|
Veterans | 1 | 2022 | 2656 | 0.080 |
Why?
|
Male | 17 | 2024 | 360703 | 0.080 |
Why?
|
Prospective Studies | 3 | 2024 | 54437 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2024 | 7571 | 0.080 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2813 | 0.070 |
Why?
|
Proteinuria | 2 | 2024 | 605 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1812 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2570 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2015 | 1390 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7226 | 0.070 |
Why?
|
Adult | 10 | 2024 | 221120 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3803 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2024 | 64681 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1893 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39127 | 0.060 |
Why?
|
Skin | 3 | 2014 | 4473 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 1743 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 80675 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9567 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2024 | 2410 | 0.050 |
Why?
|
Neutrophils | 1 | 2015 | 3763 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2182 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3788 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 463 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4107 | 0.050 |
Why?
|
Mutation | 4 | 2021 | 30004 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5665 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9458 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 265 | 0.040 |
Why?
|
Transcription Factor DP1 | 1 | 2018 | 136 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3758 | 0.040 |
Why?
|
Macrophages | 1 | 2014 | 5755 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 380 | 0.040 |
Why?
|
Thalidomide | 2 | 2015 | 885 | 0.040 |
Why?
|
Boronic Acids | 2 | 2013 | 915 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3446 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 178 | 0.040 |
Why?
|
Stromal Cells | 1 | 2024 | 1329 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2018 | 10423 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 442 | 0.040 |
Why?
|
Pyrazines | 2 | 2013 | 1202 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 517 | 0.030 |
Why?
|
Azepines | 1 | 2018 | 328 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 930 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1651 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2009 | 3032 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2014 | 22174 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16575 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 662 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2017 | 375 | 0.030 |
Why?
|
Glomerular Basement Membrane | 1 | 2015 | 35 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9297 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2017 | 424 | 0.030 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2015 | 27 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2019 | 613 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1668 | 0.030 |
Why?
|
Lichen Planus, Oral | 1 | 2015 | 57 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13632 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1078 | 0.030 |
Why?
|
Women's Health | 1 | 2024 | 2070 | 0.030 |
Why?
|
Point Mutation | 1 | 2019 | 1593 | 0.030 |
Why?
|
Common Variable Immunodeficiency | 1 | 2015 | 100 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10759 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1217 | 0.030 |
Why?
|
Caspases | 1 | 2017 | 878 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2018 | 974 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2621 | 0.030 |
Why?
|
Thymoma | 1 | 2015 | 188 | 0.030 |
Why?
|
Agammaglobulinemia | 1 | 2015 | 172 | 0.030 |
Why?
|
Risk Factors | 4 | 2024 | 74241 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 345 | 0.030 |
Why?
|
Triazoles | 1 | 2018 | 902 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1652 | 0.030 |
Why?
|
Fibrinogens, Abnormal | 1 | 2012 | 10 | 0.030 |
Why?
|
Cryoglobulins | 1 | 2012 | 58 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2024 | 0.030 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2012 | 83 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1334 | 0.030 |
Why?
|
Leg Ulcer | 1 | 2012 | 71 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2015 | 646 | 0.030 |
Why?
|
DNA Replication | 1 | 2019 | 1415 | 0.030 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2012 | 170 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22142 | 0.020 |
Why?
|
Cell Movement | 1 | 2024 | 5195 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20982 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2452 | 0.020 |
Why?
|
Phylogeny | 1 | 2019 | 2809 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1741 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18384 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2329 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18222 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3606 | 0.020 |
Why?
|
Animals | 4 | 2020 | 168089 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41496 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2911 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12474 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3593 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1610 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9319 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1565 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3412 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9721 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2392 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5778 | 0.020 |
Why?
|
Colitis | 1 | 2015 | 1234 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12952 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14610 | 0.020 |
Why?
|
Ischemia | 1 | 2014 | 1889 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2635 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4384 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1186 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7851 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1812 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6304 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 3025 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4744 | 0.010 |
Why?
|
Headache | 1 | 2009 | 1255 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12940 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6781 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9478 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 1923 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11512 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12676 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11119 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39957 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10203 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21366 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88300 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23419 | 0.010 |
Why?
|
United States | 1 | 2021 | 72341 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81330 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36415 | 0.000 |
Why?
|
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore